- Home
- SXTP vs TTNP Comparison
SXTP vs TTNP Comparison
Compare SXTP & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- TTNP
- Stock Information
- Founded
- SXTP 2010
- TTNP 1991
- Country
- SXTP United States
- TTNP United States
- Employees
- SXTP N/A
- TTNP N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SXTP Health Care
- TTNP Health Care
- Exchange
- SXTP Nasdaq
- TTNP Nasdaq
- Market Cap
- SXTP 2.7M
- TTNP 3.0M
- IPO Year
- SXTP 2023
- TTNP 1996
- Fundamental
- Price
- SXTP $0.83
- TTNP $3.79
- Analyst Decision
- SXTP Hold
- TTNP
- Analyst Count
- SXTP 1
- TTNP 0
- Target Price
- SXTP N/A
- TTNP N/A
- AVG Volume (30 Days)
- SXTP 967.9K
- TTNP 41.9K
- Earning Date
- SXTP 11-14-2024
- TTNP 01-03-2025
- Dividend Yield
- SXTP N/A
- TTNP N/A
- EPS Growth
- SXTP N/A
- TTNP N/A
- EPS
- SXTP N/A
- TTNP N/A
- Revenue
- SXTP $462,612.00
- TTNP N/A
- Revenue This Year
- SXTP $141.35
- TTNP N/A
- Revenue Next Year
- SXTP $175.16
- TTNP N/A
- P/E Ratio
- SXTP N/A
- TTNP N/A
- Revenue Growth
- SXTP 128.99
- TTNP N/A
- 52 Week Low
- SXTP $0.70
- TTNP $3.03
- 52 Week High
- SXTP $10.67
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- SXTP 36.41
- TTNP 48.54
- Support Level
- SXTP $0.87
- TTNP $3.14
- Resistance Level
- SXTP $0.95
- TTNP $3.38
- Average True Range (ATR)
- SXTP 0.14
- TTNP 0.22
- MACD
- SXTP -0.06
- TTNP 0.02
- Stochastic Oscillator
- SXTP 6.99
- TTNP 52.24
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.